Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/16/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Michael Haude?

Michael Haude

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Course Director

PCRonline


Affiliations

EuroPCR

Board Member


European Society of Cardiology

Member


Education

M.D.


Web References(73 Total References)


Board Members

www.pcronline.com [cached]

Michael Haude
Michael Haude Interventional cardiologist / Cardiologist


www.dicardiology.com

Michael Haude, M.D., of the Lukaskrankenhaus, Neuss, Germany, principal investigator of the study, commented:


www.dicardiology.com

"These results offer the first confirmation of Magmaris's longer-term safety and efficacy," stated BIOSOLVE-II principal investigator Dr. Michael Haude of the Lukaskrankenhaus, Neuss, Germany.


www.dicardiology.com

"The results of BIOSOLVE-II confirm that the Biotronik Magnesium Scaffold is both a safe and effective option for treating coronary artery disease (CAD), and establish it as the first clinically-proven magnesium-based bioresorbable scaffold," commented principal investigator of the study Michael Haude, M.D., of the Lukaskrankenhaus, Neuss, Germany.
It is based on a natural element widely present in the human body, and the magnesium-based properties promote a faster and simpler implantation procedure," commented Haude.


Faculty - CRF

www.crf.org [cached]

Michael Haude, MD, PhD
Lukaskrankenhaus Neuss


Similar Profiles

Other People with this Name

Other People with the name Haude

Ellen Haude

EMH Financial Services, LLC

Daniel Haude

Reminger Co

Michael Haude

Jim Haude

Club Crabtowne Inc

Hubert Haude

EURODEV PROJECTS LTD

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory